Similar articles

• Asenapine (Saphris) sublingual tablets for schizophrenia and bipolar disorder.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 2010 Feb 8;52(1331):9-10. Med Lett Drugs Ther. 2010. PMID: 20216523 Review. No abstract available.
• Asenapine.

  Meltzer HY, Dritselis A, Yasothan U, Kirkpatrick P. Meltzer HY, et al. Nat Rev Drug Discov. 2009 Nov;8(11):843-4. doi: 10.1038/nrd3027. Nat Rev Drug Discov. 2009. PMID: 19876039
• ACS chemical neuroscience molecule spotlight on Saphris.

  Hopkins CR. Hopkins CR. ACS Chem Neurosci. 2010 Apr 21;1(4):263-4. doi: 10.1021/cn100022a. ACS Chem Neurosci. 2010. PMID: 22778826 Free PMC article.
• Asenapine review, part II: clinical efficacy, safety and tolerability.

  Citrome L. Citrome L. Expert Opin Drug Saf. 2014 Jun;13(6):803-30. doi: 10.1517/14740338.2014.908183. Epub 2014 May 3. Expert Opin Drug Saf. 2014. PMID: 24793161 Review.
• Update on newer antipsychotic drugs.

  Howland RH. Howland RH. J Psychosoc Nurs Ment Health Serv. 2011 Apr;49(4):13-5. doi: 10.3928/02793695-20110311-99. Epub 2011 Mar 30. J Psychosoc Nurs Ment Health Serv. 2011. PMID: 21446639